LJ401-BT01 - A multi-center, randomized, open-label, parallel-group study with LJPC-401 for the treatment of myocardial iron overload in adult patients with transfusion-dependent beta thalassemia

Project: Research project

Project Details

StatusActive
Effective start/end date5/25/188/31/50

Funding

  • La Jolla Pharmaceutical Company
  • La Jolla Pharmaceutical Company